How does insulin therapy interact with novel GLP-1 receptor agonists, and what are the benefits of combination therapy for diabetes management?
Share
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Insulin therapy and GLP-1 receptor agonists like exenatide work synergistically, improving glucose control and often reducing the required insulin dose, thus enhancing weight loss and glycemic control.